Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute leukemia: a pediatric perspective.

James R Downing1, Kevin M Shannon

  • 1Department of Pathology, St Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38105, USA. jim.downing@stjude.org

Cancer Cell
|December 25, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Demonstration of Coronary Sinus Reentry by Ultrahigh-Resolution Mapping in Adults With Congenital Heart Disease.

Circulation. Arrhythmia and electrophysiology·2025
Same author

Improving survival and reducing suffering for children with NCDs.

Lancet (London, England)·2025
Same author

Genomic landscape and clonal architecture in pediatric myeloid neoplasms with chromosome 7 deletions.

Blood neoplasia·2025
Same author

The Global Platform for Access to Childhood Cancer Medicines: addressing inequities in childhood cancer care.

The Lancet. Oncology·2025
Same author

Age-Related Ventricular Tachycardia Substrate Characteristics for Repaired Tetralogy of Fallot Before Transcatheter Pulmonary Valve Placement.

JACC. Clinical electrophysiology·2025
Same author

Multidetector Computed Tomography Assessment of Anatomical Ventricular Tachycardia Isthmuses in Repaired Tetralogy of Fallot.

JACC. Clinical electrophysiology·2024
Same journal

Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.

Cancer cell·2026
Same journal

Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption.

Cancer cell·2026
Same journal

Intratumoral B cells under stress.

Cancer cell·2026
Same journal

Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth.

Cancer cell·2026
Same journal

Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts.

Cancer cell·2026
Same journal

OpenIO: An open framework for AI-native immunotherapy.

Cancer cell·2026
See all related articles

Pediatric acute leukemia and myelodysplastic syndrome studies offer unique insights into adult hematopoietic malignancies. Understanding these differences aids in developing targeted treatments for both age groups.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Pathology

Background:

  • Hematological malignancies present differently in pediatric versus adult patients.
  • Diseases like acute lymphoblastic leukemia, acute myeloid leukemia, and myelodysplastic syndrome exhibit distinct biological characteristics and treatment responses based on age.
  • Existing research highlights significant variations in the molecular underpinnings of these conditions between children and adults.

Purpose of the Study:

  • To review the current understanding of the molecular pathology in acute leukemia and myelodysplastic syndrome.
  • To emphasize the contributions of pediatric studies to the knowledge of adult hematopoietic malignancies.
  • To bridge the understanding gap between pediatric and adult hematological malignancies.

Main Methods:

Related Experiment Videos

  • Literature review of studies focusing on molecular pathology of acute leukemia and myelodysplastic syndrome.
  • Comparative analysis of pediatric and adult patient data.
  • Synthesis of current research findings on molecular differences and treatment responses.

Main Results:

  • Significant molecular distinctions exist in acute leukemia and myelodysplastic syndrome between pediatric and adult populations.
  • Pediatric-specific research provides novel insights into the pathogenesis of adult hematopoietic malignancies.
  • Age-related variations impact treatment efficacy and disease outcomes.

Conclusions:

  • Understanding the molecular pathology of pediatric hematopoietic malignancies is crucial for advancing adult cancer treatment.
  • Further research integrating pediatric and adult data can lead to more effective therapeutic strategies.
  • The distinct biology of childhood leukemia and MDS offers valuable lessons for adult oncology.